ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Protagonist Therapeutics Inc

Protagonist Therapeutics Inc (PTGX)

38,67
-0,01
(-0,03%)
Fermé 15 Février 10:00PM
38,67
0,01
(0,03%)
Après les heures de négociation: 10:00PM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
38,67
Prix Achat
37,45
Prix Vente
39,77
Volume échangé
366 939
38,36 Fourchette du Jour 39,37
24,22 Plage de 52 semaines 48,89
Cap du marché
Clôture Veille
38,68
Ouverture
38,74
Dernière Transaction
15
@
38
Dernière heure de transaction
Volume financier
US$ 14 213 278
VWAP
38,7347
Volume moyen (3 m)
638 961
Actions en circulation
59 598 018
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-29,18
Bénéfice par action (BPA)
-1,32
Chiffre d'affairess
60M
Bénéfice net
-78,96M

À propos de Protagonist Therapeutics Inc

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. The Company operates and manages its business as one operating se... Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. The Company operates and manages its business as one operating segment. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Protagonist Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker PTGX. Le dernier cours de clôture d'Protagonist Therapeutics était de US$38,68. Au cours de la dernière année, les actions de Protagonist Therapeutics ont été négociées dans une fourchette de prix de US$ 24,22 à US$ 48,89.

Protagonist Therapeutics compte actuellement 59 598 018 actions en circulation. La capitalisation boursière d'Protagonist Therapeutics est de US$2,31 milliard. Protagonist Therapeutics a un ratio cours/bénéfice (ratio PE) de -29.18.

Flux d'options Protagonist Therapeutics (PTGX)

Flux global

Baissier

Prime nette

-219k

Calls / Puts

40,00%

Ach. / Vent.

100,00%

OTM / ITM

40,00%

Sweeps Ratio

0,00%

PTGX Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.862.2745305474737.8139.6636.3463209737.92129198CS
41.694.570037858336.9839.8936.3452845137.8422616CS
12-4.63-10.692840646743.348.2835.0363896140.22928121CS
26-1.75-4.3295398317740.4248.8933.3164571942.42676841CS
5211.2240.874316939927.4548.8924.2268704837.0632089CS
15611.3941.752199413527.2848.896.9192031022.01196593CS
26030.11351.7523364498.5650.545.382164223.10236245CS

PTGX - Frequently Asked Questions (FAQ)

What is the current Protagonist Therapeutics share price?
The current share price of Protagonist Therapeutics is US$ 38,67
How many Protagonist Therapeutics shares are in issue?
Protagonist Therapeutics has 59 598 018 shares in issue
What is the market cap of Protagonist Therapeutics?
The market capitalisation of Protagonist Therapeutics is USD 2,31B
What is the 1 year trading range for Protagonist Therapeutics share price?
Protagonist Therapeutics has traded in the range of US$ 24,22 to US$ 48,89 during the past year
What is the PE ratio of Protagonist Therapeutics?
The price to earnings ratio of Protagonist Therapeutics is -29,18
What is the cash to sales ratio of Protagonist Therapeutics?
The cash to sales ratio of Protagonist Therapeutics is 38,4
What is the reporting currency for Protagonist Therapeutics?
Protagonist Therapeutics reports financial results in USD
What is the latest annual turnover for Protagonist Therapeutics?
The latest annual turnover of Protagonist Therapeutics is USD 60M
What is the latest annual profit for Protagonist Therapeutics?
The latest annual profit of Protagonist Therapeutics is USD -78,96M
What is the registered address of Protagonist Therapeutics?
The registered address for Protagonist Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Protagonist Therapeutics website address?
The website address for Protagonist Therapeutics is www.protagonist-inc.com
Which industry sector does Protagonist Therapeutics operate in?
Protagonist Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
JTAIJet AI Inc
US$ 6,02
(133,33%)
104,48M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
254,39M
WRDWeRide Inc
US$ 31,4877
(83,39%)
21,07M
INLFINLIF Limited
US$ 16,27
(80,58%)
7,68M
MBRXMoleculin Biotech Inc
US$ 2,1201
(66,94%)
136,66M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3,08
(-56,31%)
430,77k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3,36
(-52,68%)
5,21k
CSAICloudastructure Inc
US$ 19,0001
(-49,58%)
1,03M
NEXNNexxen International Ltd
US$ 10,30
(-49,16%)
164,82k
BSLKBolt Projects Holdings Inc
US$ 0,6626
(-46,13%)
13,4M
CNSPCNS Pharmaceuticals Inc
US$ 0,1415
(31,26%)
489,28M
MGOLMGO Global Inc
US$ 0,7176
(-15,08%)
417,31M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
254,39M
INTCIntel Corporation
US$ 23,60
(-2,20%)
230,26M
NVDANVIDIA Corporation
US$ 138,85
(2,63%)
194,99M
Aucune Discussion Trouvée
Ajouter une Discussion